Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
How cognitive and reactive fear circuits optimize escape decisions in humans
2018 StandoutNobel
A Neural Circuit for Memory Specificity and Generalization
2013 StandoutScienceNobel
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression
2011
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
The Hallucinogen DOI Reduces Low-Frequency Oscillations in Rat Prefrontal Cortex: Reversal by Antipsychotic Drugs
2008
Disruption of Prefrontal Cortex Large Scale Neuronal Activity by Different Classes of Psychotomimetic Drugs
2012
Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges
2001
Fos expression following self-stimulation of the medial prefrontal cortex
2000
Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
1990
Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala
2007
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Brain anatomy and sensorimotor gating in Asperger's syndrome
2002
Hypothalamic regulation of sleep and circadian rhythms
2005 StandoutNature
Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon
2000
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
2004
Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task
2003
Getting Formal with Dopamine and Reward
2002 Standout
Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)
1993
Clozapine improves dizocilpine-induced delayed alternation impairment in rats
1993
Distribution of orexin receptor mRNA in the rat brain
1998
Dopamine Is Necessary for Cue-Dependent Fear Conditioning
2009
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
Schizophrenia
2009 Standout
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Arousal and reward: a dichotomy in orexin function
2006
In Vivo Modulation of the Activity of Pyramidal Neurons in the Rat Medial Prefrontal Cortex by 5-HT2A Receptors: Relationship to Thalamocortical Afferents
2003
Effects of local application of dopaminergic drugs into the dorsal part of the medial prefrontal cortex of rats in a delayed matching to position task: comparison with local cholinergic blockade
1994
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Effects of stress throughout the lifespan on the brain, behaviour and cognition
2009 Standout
Psychedelics
2016 Standout
The human raphe nuclei and the serotonergic system
2003
Sensorimotor Gating Deficits in Adults with Autism
2006
Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats
1993
Molecular Dynamics Simulation for All
2018 Standout
Group II Metabotropic Glutamate Receptor Modulation of DOI-induced c-fos mRNA and Excitatory Responses in the Cerebral Cortex
2003
Behavioral Correlates of Activity in Identified Hypocretin/Orexin Neurons
2005
Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs
1995
Functional Imaging of Neural Responses to Expectancy and Experience of Monetary Gains and Losses
2001 StandoutNobel
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
2014
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Mice Deficient in Golf Are Anosmic
1998 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
The two faces of the pharmacological interaction of mGlu2 and 5-HT2A – Relevance of receptor heterocomplexes and interaction through functional brain pathways
2013
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor
2010 StandoutNatureNobel
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo–pituitary–adrenocortical responsiveness
2003
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
1993
Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat
2006
Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonists
2016
The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies
2004
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
2008
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
1999
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
2009
The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats
2003
Stress and the brain: from adaptation to disease
2005 Standout
Narcolepsy in orexin Knockout Mice
1999 Standout
Cellular perspectives on the glutamate–monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders
2002
Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia
2008
Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats
1992
Lysergic acid diethylamide and [−]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex
2004
Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review
2001
The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene
1999 Standout
Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine
1998
Functional mapping and annotation of genetic associations with FUMA
2017 Standout
What we can do and what we cannot do with fMRI
2008 StandoutNature
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
2009
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex
2001
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Chromosome conformation elucidates regulatory relationships in developing human brain
2016 Nature
Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group
2002
Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior
2007
Localization of drug reward mechanisms by intracranial injections
1992
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
1999
Inbred strain differences in prepulse inhibition of the mouse startle response
1997
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
1989 StandoutNobel
Alzheimer's Disease
2004 Standout
Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala
2004
Structure and dynamics of the M3 muscarinic acetylcholine receptor
2012 StandoutNatureNobel
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats
2003
Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors
2002
Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens
1996
Impairments of movement initiation and execution induced by a blockade of dopamine D1 OR D2 receptors are reversed by a blockade of N-methyl-d-aspartate receptors
1996
Administration of SCH 23390 into the Medial Prefrontal Cortex Blocks the Expression of MDMA-Induced Behavioral Sensitization in Rats: An Effect Mediated by 5-HT2C Receptor Stimulation and not by D1 Receptor Blockade
2005
Prefrontal Cortex Cognitive Deficits in Children Treated Early and Continuously for PKU
1997
Clinical Experience With Excitatory Amino Acid Antagonist Drugs
1995
A Neural Substrate of Prediction and Reward
1997 StandoutScience
Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes
2016
Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors
1995
p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling
2006
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress
2006 StandoutScience
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
D1Receptor Modulation of Hippocampal–Prefrontal Cortical Circuits Integrating Spatial Memory with Executive Functions in the Rat
1998
Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys.
1996
The Role of Kv1.2-Containing Potassium Channels in Serotonin-Induced Glutamate Release from Thalamocortical Terminals in Rat Frontal Cortex
2001
Precise Modulation of CO2 Sorption in Ti8Ce2–Oxo Clusters: Elucidating Lewis Acidity of the Ce Metal Sites and Structural Flexibility
2024 StandoutNobel
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 Standout
Executive Functions
2012 Standout
Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism
2001
Kinetic Target-Guided Synthesis in Drug Discovery and Chemical Biology: A Comprehensive Facts and Figures Survey
2016
Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model
2012
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
2002
Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex
2003
Emerging drugs for schizophrenia
2008
Serotonin Receptors
2008
Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts
2018
THE BASAL GANGLIA: FOCUSED SELECTION AND INHIBITION OF COMPETING MOTOR PROGRAMS
1996 Standout
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755
1996
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
1998 Science
Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments
2009 StandoutNobel
Hallucinogens
2004 Standout
Works of Michael Bubser being referenced
Disinhibition of the mediodorsal thalamus induces Fos-like immunoreactivity in both pyramidal and GABA-containing neurons in the medial prefrontal cortex of rats, but does not affect prefrontal extracellular GABA levels
1998
The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease
2011
Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia
2011
Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats
1992
Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats
1989
Modulatory role of catecholamines in the transsynaptic expression of c-fos in the rat medial prefrontal cortex induced by disinhibition of the mediodorsal thalamus: a study employing microdialysis and immunohistochemistry
1997
Novel Selective Allosteric Activator of the M1Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats
2008
Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex
1994
Thalamic paraventricular nucleus neurons collateralize to innervate the prefrontal cortex and nucleus accumbens
1998
Neurotransmitter concentrations and binding at dopamine receptors in rats after maternal exposure to 3,4,3′,4′-tetrachlorobiphenyl: the role of reduced thyroid hormone concentrations
2001
Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum
2002
Distribution of serotonin 5-HT2A receptors in afferents of the rat striatum
2001
6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze
1990
Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats
1995
Deficient Sensorimotor Gating After 6‐Hydroxydopamine Lesion of the Rat medial Prefrontal Cortex is Reversed by Haloperidol
1994
Stress induces Fos expression in neurons of the thalamic paraventricular nucleus that innervate limbic forebrain sites
1999
6-Hydroxydopamine lesion of the rat prefrontal cortex impairs motor initiation but not motor execution
1994
Discovery and Characterization of ML398, a Potent and Selective Antagonist of the D4Receptor within VivoActivity
2014
Behavioural pharmacology of glutamate in the basal ganglia
1992
Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation
1999
Psychostimulant-Induced Fos Protein Expression in the Thalamic Paraventricular Nucleus
1998
DOI-Induced Activation of the Cortex: Dependence on 5-HT2AHeteroceptors on Thalamocortical Glutamatergic Neurons
2000
Differential Activation of Orexin Neurons by Antipsychotic Drugs Associated with Weight Gain
2002